Cormorant Asset Management as of June 30, 2021
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 103 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Turning Point Therapeutics I | 8.0 | $237M | 3.0M | 78.02 | |
Ishares Tr Russell 2000 Etf Put Option (IWM) | 7.8 | $229M | 1.0M | 229.37 | |
Atea Pharmaceuticals (AVIR) | 4.7 | $138M | 6.4M | 21.48 | |
Forma Therapeutics Hldgs SHS | 4.0 | $118M | 4.7M | 24.89 | |
Bridgebio Pharma (BBIO) | 3.9 | $115M | 1.9M | 60.96 | |
Design Therapeutics (DSGN) | 3.6 | $106M | 5.4M | 19.57 | |
Revolution Medicines (RVMD) | 3.6 | $106M | 3.3M | 31.74 | |
Olema Pharmaceuticals (OLMA) | 2.9 | $86M | 3.1M | 27.98 | |
Bioatla (BCAB) | 2.8 | $83M | 2.0M | 42.38 | |
Monte Rosa Therapeutics (GLUE) | 2.4 | $70M | 3.2M | 21.78 | |
Ark Etf Tr Genomic Rev Etf Put Option (ARKG) | 2.4 | $69M | 750k | 92.50 | |
Edgewise Therapeutics (EWTX) | 2.3 | $67M | 3.1M | 21.18 | |
Ark Etf Tr Innovation Etf Put Option (ARKK) | 2.2 | $65M | 500k | 130.78 | |
Avidity Biosciences Ord (RNA) | 1.9 | $55M | 2.2M | 24.71 | |
Apellis Pharmaceuticals (APLS) | 1.8 | $54M | 850k | 63.20 | |
Alx Oncology Hldgs (ALXO) | 1.7 | $49M | 890k | 54.68 | |
Biomea Fusion (BMEA) | 1.6 | $48M | 3.2M | 15.27 | |
Ambrx Biopharma Sponsored Ads | 1.6 | $47M | 2.5M | 18.92 | |
Zymeworks | 1.6 | $46M | 1.3M | 34.69 | |
Aerovate Therapeutics (AVTE) | 1.5 | $45M | 2.0M | 21.97 | |
Prometheus Biosciences | 1.5 | $45M | 1.8M | 24.07 | |
Tarsus Pharmaceuticals (TARS) | 1.5 | $44M | 1.5M | 28.98 | |
Stoke Therapeutics (STOK) | 1.5 | $43M | 1.3M | 33.66 | |
Rocket Pharmaceuticals (RCKT) | 1.5 | $43M | 969k | 44.29 | |
Verve Therapeutics (VERV) | 1.4 | $41M | 709k | 57.24 | |
Rain Therapeutics | 1.3 | $40M | 2.6M | 15.13 | |
Aclaris Therapeutics (ACRS) | 1.2 | $35M | 2.0M | 17.56 | |
Omeros Corporation (OMER) | 1.1 | $33M | 2.2M | 14.84 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.1 | $31M | 1.4M | 21.76 | |
Mirati Therapeutics | 1.0 | $28M | 175k | 161.53 | |
Y Mabs Therapeutics (YMAB) | 0.9 | $27M | 800k | 33.80 | |
Agenus Com New (AGEN) | 0.9 | $26M | 4.8M | 5.49 | |
Elevation Oncology (ELEV) | 0.9 | $26M | 2.0M | 12.89 | |
Vectivbio Hldg Ord Shs | 0.9 | $26M | 2.2M | 11.47 | |
Twist Bioscience Corp (TWST) | 0.8 | $25M | 185k | 133.25 | |
Reata Pharmaceuticals Cl A | 0.8 | $24M | 168k | 141.53 | |
Acceleron Pharma | 0.7 | $22M | 175k | 125.49 | |
908 Devices (MASS) | 0.7 | $21M | 545k | 38.75 | |
Blueprint Medicines (BPMC) | 0.7 | $21M | 238k | 87.96 | |
Longboard Pharmaceuticals In (LBPH) | 0.7 | $21M | 2.3M | 8.99 | |
Igm Biosciences (IGMS) | 0.7 | $21M | 250k | 83.20 | |
Axonics Modulation Technolog (AXNX) | 0.7 | $20M | 322k | 63.41 | |
Praxis Precision Medicines I | 0.6 | $19M | 1.0M | 18.28 | |
Dermtech Ord ord (DMTK) | 0.6 | $19M | 450k | 41.57 | |
Aligos Therapeutics (ALGS) | 0.6 | $19M | 906k | 20.39 | |
Talaris Therapeutics | 0.6 | $17M | 1.2M | 14.20 | |
Akero Therapeutics (AKRO) | 0.5 | $15M | 600k | 24.81 | |
Pliant Therapeutics (PLRX) | 0.5 | $14M | 482k | 29.12 | |
Cabaletta Bio (CABA) | 0.5 | $14M | 1.6M | 8.60 | |
Pharvaris N V (PHVS) | 0.5 | $14M | 745k | 18.30 | |
C4 Therapeutics Com Stk (CCCC) | 0.5 | $13M | 355k | 37.84 | |
Beam Therapeutics (BEAM) | 0.4 | $13M | 100k | 128.71 | |
Connect Biopharma Hldgs Ads (CNTB) | 0.4 | $13M | 650k | 19.53 | |
Aptose Biosciences Com New | 0.4 | $13M | 3.8M | 3.32 | |
Gh Research Ordinary Shares (GHRS) | 0.4 | $13M | 608k | 20.64 | |
Myovant Sciences | 0.4 | $12M | 543k | 22.77 | |
Repare Therapeutics Ord (RPTX) | 0.4 | $11M | 364k | 31.18 | |
Eledon Pharmaceuticals (ELDN) | 0.4 | $11M | 1.4M | 7.91 | |
Morphic Hldg (MORF) | 0.4 | $11M | 190k | 57.39 | |
Humanigen Com New (HGENQ) | 0.4 | $10M | 600k | 17.38 | |
Anaptysbio Inc Common (ANAB) | 0.3 | $10M | 385k | 25.93 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 0.3 | $9.9M | 75k | 131.55 | |
Zai Lab Adr (ZLAB) | 0.3 | $9.5M | 54k | 176.99 | |
Inspire Med Sys (INSP) | 0.3 | $9.3M | 48k | 193.26 | |
Bctg Acquisition Corp | 0.3 | $9.1M | 800k | 11.37 | |
Galecto (GLTO) | 0.3 | $8.9M | 1.8M | 5.06 | |
Tcr2 Therapeutics Inc cs | 0.3 | $7.9M | 480k | 16.41 | |
Harpoon Therapeutics | 0.3 | $7.5M | 541k | 13.87 | |
Catabasis Pharmaceuticals In Com New | 0.3 | $7.5M | 3.6M | 2.11 | |
Iteos Therapeutics (ITOS) | 0.3 | $7.4M | 288k | 25.65 | |
Silverback Therapeutics (SPRY) | 0.3 | $7.4M | 239k | 30.89 | |
Uniqure Nv SHS (QURE) | 0.3 | $7.4M | 240k | 30.80 | |
Insmed Com Par $.01 (INSM) | 0.2 | $7.1M | 250k | 28.46 | |
Female Health (VERU) | 0.2 | $6.5M | 800k | 8.07 | |
Miragen Therapeutics (VRDN) | 0.2 | $6.3M | 343k | 18.29 | |
Merus N V (MRUS) | 0.2 | $6.0M | 285k | 21.07 | |
Graphite Bio | 0.2 | $5.9M | 203k | 29.19 | |
Aveo Pharmaceuticals Com New | 0.2 | $5.9M | 894k | 6.59 | |
Deciphera Pharmaceuticals (DCPH) | 0.2 | $5.3M | 144k | 36.61 | |
Akouos | 0.2 | $5.0M | 395k | 12.55 | |
Sorrento Therapeutics Com New (SRNEQ) | 0.2 | $4.8M | 500k | 9.69 | |
Magenta Therapeutics | 0.2 | $4.7M | 478k | 9.78 | |
Helix Acquisition Corp Com Cl A | 0.2 | $4.4M | 430k | 10.35 | |
Quotient SHS | 0.1 | $4.4M | 1.2M | 3.64 | |
Theravance Biopharma (TBPH) | 0.1 | $4.4M | 300k | 14.52 | |
Precision Biosciences Ord | 0.1 | $4.3M | 347k | 12.52 | |
5 01 Acquisition Corp Com Cl A | 0.1 | $4.0M | 400k | 9.97 | |
Genetron Hldgs Ads | 0.1 | $2.7M | 133k | 20.14 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $2.6M | 392k | 6.64 | |
Health Sciences Acq Corp 2 Ord Shs | 0.1 | $2.4M | 240k | 10.20 | |
Eiger Biopharmaceuticals | 0.1 | $2.4M | 285k | 8.52 | |
Atreca Cl A Com (BCEL) | 0.1 | $2.3M | 274k | 8.52 | |
Tricida | 0.1 | $1.8M | 428k | 4.32 | |
Gossamer Bio (GOSS) | 0.1 | $1.6M | 198k | 8.12 | |
Springworks Therapeutics (SWTX) | 0.0 | $1.2M | 15k | 82.40 | |
Orchard Therapeutics Ads | 0.0 | $1.1M | 257k | 4.39 | |
X4 Pharmaceuticals (XFOR) | 0.0 | $676k | 104k | 6.50 | |
Cardiff Oncology (CRDF) | 0.0 | $637k | 96k | 6.65 | |
Minerva Neurosciences | 0.0 | $570k | 246k | 2.32 | |
Imv | 0.0 | $507k | 234k | 2.16 | |
Cerevel Therapeutics Hldng I *w Exp 06/09/202 (CEREW) | 0.0 | $278k | 19k | 14.39 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $217k | 83k | 2.60 | |
Outlook Therapeutics *w Exp 02/18/202 | 0.0 | $130k | 417k | 0.31 |